Barbitúricos
Barbitúricos
Barbitúricos
Cyclobarbital
Hypnotic, Barbiturate
Synonyms. Ciclobarbital; Cyclobarbitalum; Cyclobarbitone; Ethylhexabital;
Hexemalum; Tetrahydrophenobarbital.
Proprietary names. Cavonyl; Cyclodorm; Cyklodorm; Fanodormo; Irifan; Namuron;
Palinum; Phanodorm; Phanodorn; Philodorm; Prälumin; Pro-Sonil; Sonaform.
Note.
5-(1-Cyclohexen–1–yl)-5–ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione
C12H16N2O3=236.3
CAS—52–31–3
A white crystalline powder, which gradually decomposes on storage. M.p. 171° to 174°.
Cyclobarbital Calcium
Synonyms. Ciclobarbital Calcium; Cyclobarbitone Calcium; Hexemalcalcium.
Proprietary name. It is an ingredient of Domidorm.
(C12H15N2O3)2Ca=510.6
CAS-143–76–0
pKa7.6 (20°).
Partition Coefficient.
Colour Tests.
1.4 Procedimiento
Se usarán los extractos obtenidos en el aislamiento de los T.O.F. y se procederá a realizar las diferentes
reacciones de reconocimiento.
. Rx de reconocimiento de Barbitúricos:
- Rx de Parry-Coppangy
* M.P. 5 mL.
* Observar la coloración.
- Rx de Zwiker:
* M.P. 5 mL.
* Agitar fuertemente
Thin–layer Chromatography.
System TD—Rf 50; system TE—Rf 40; system TF—Rf 64; system TH—Rf 59; system
TAD—Rf 58; system TAE—Rf 88. (Mercuric chloride–diphenylcarbazone reagent,
positive; mercurous nitrate spray, black; acidified potassium permanganate solution,
yellow–brown; Zwikker's reagent, pink.)
Ultraviolet Spectrum.
Borax buffer 0.05 M (pH 9.2)—239 nm (A11=410a); 1 M sodium hydroxide (pH 13)—
256 nm (A11=320b).
Rapidly absorbed after oral administration. The main metabolic reaction appears to be
oxidation to ketocyclobarbital [5-(3–oxocyclohex–1–enyl)-5–ethylbarbituric acid]. Less
than 10% of a dose is excreted in the urine unchanged.
THERAPEUTIC CONCENTRATION.
In plasma, usually in the range 2 to 10 mg/L.
After a single oral dose of 300 mg of the calcium salt, given to 6 subjects, peak plasma
concentrations of 7.4 to 10.3 mg/L (mean 8.7) were attained in 0.7 to 2.5 h. [D. D.
Breimer and A. C. M. Winten,Eur. J. Clin. Pharmacol.,1976, 9, 443–450.]
TOXICITY.
The estimated minimum lethal dose is 2 g. Severe toxic effects are associated with
blood concentrations greater than 10 mg/L.
HALF–LIFE.
Plasma half–life, 8 to 17 h (mean 12), increased in subjects with liver disease.
VOLUME OF DISTRIBUTION.
About 0.5 L/kg.
CLEARANCE.
Plasma clearance, about 0.5 mL/min/kg.
PROTEIN BINDING.
In plasma, about 70%.
Dose.